March 2016 Archive

Posted by Burton on March 25th, 2016 in Headlines Corporate Announcements  ⟩  0 comments


Lee Biosolutions is proud to announce the purchase of Creative Laboratory Products, Inc, complete product line. CLP was an Indianapolis, Indiana-based producer of human and animal cholesterol concentrates, such as Low Density Lipoprotein (LDL), High Density Lipoprotein(HDL) and delipidized serum products and sold the product line to Lee Biosolutions, Inc, on March 14th, 2016.

We are very happy to have their manufacturing team headed by Jason Proksch join Lee Biosolutions . Lee Bio will be assisting them with their move to St. Louis, MO. Transfer of technology and equipment to Lee Biosolutions manufacturing facility will be taking place during the next couple of months as the team wraps up current production. Lee Biosolutions will be utilizing CLP protocols and test methods, ensuring customers won’t be affected during the transition. Lee Bio team is preparing to perform Installation Qualifications (IQ) and Operational Qualifications (OQ) on equipment and instrumentation that is used in the production and testing of these products.

Burton Lee, CEO of Lee Bio says, “Dr. Gary Proksch , founder of Creative Laboratory Products was the first person to recognize the future of the lipoprotein market 30 years ago and his technology in providing stable, high quality lipoproteins has enabled diagnostic manufacturers worldwide to produce hundreds of millions of cholesterol tests over the years that have saved lives and created the market as we know today."

Matt Lee, President and COO says, " The addition of Bovine HDL , Bovine LDL Cholesterol Concentrate, Human LDL and HDL, delipidized serum and related products strengthens and expands our core product line providing both significant growth and capabilities allowing us expand in key diagnostics markets."

The transition of manufacturing CLP products to Lee Biosolutions will ensure that customers will be provided with high quality and consistent long-term supply with increased capacity for decades to come. CLP and Lee Biosolutions have had a close relationship for over 30 years and Lee Biosolutions’ expertise with process development and purification of proteins derived from both animal and human sources makes this a perfect fit that will provide for a seamless transition for customers.

Lee Biosolutions is a global biotechnology leader specializing in custom and bulk manufacturing and preparation of high quality finished enzymes, related proteins and biologicals used in clinical diagnostic tests for pathologies such as cardiac disease, cancer, diabetes, urine analysis, obesity, inflammation, neurological, autoimmune diseases, immunological disorders and more The company is known internationally for developing some of the most successful formulations for research, diagnostic and therapeutic markets. Lee Biosolutions is certified to ISO 13485:2003 and ISO 9001:2008 standards.

You can learn more about the company, its products, services and career opportunities by visiting its website at